SALIX PHARMACEUTICALS LTD Finite-Lived Intangible Assets, Net
SALIX PHARMACEUTICALS LTD had Finite-Lived Intangible Assets, Net of $1.53 billion as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2015-03-02
- 2014-12-31: Finite-Lived Intangible Assets, Net $1.53B.
- 2014-09-30: Finite-Lived Intangible Assets, Net $1.74B; Finite-Lived Intangible Assets, Net as first filed $1.81B.
- 2014-06-30: Finite-Lived Intangible Assets, Net $1.77B; Finite-Lived Intangible Assets, Net as first filed $1.83B.
- 2014-03-31: Finite-Lived Intangible Assets, Net $1.82B; Finite-Lived Intangible Assets, Net as first filed $1.89B.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2014-12-31 | $1.53B 10-K · filed 2015-03-02 | |
| 2014-09-30 | $1.74B 10-Q/A · filed 2015-03-02 | $1.81B 10-Q · filed 2014-11-07 |
| 2014-06-30 | $1.77B 10-Q/A · filed 2015-03-02 | $1.83B 10-Q · filed 2014-08-08 |
| 2014-03-31 | $1.82B 10-Q/A · filed 2015-03-02 | $1.89B 10-Q · filed 2014-05-09 |
| 2013-12-31 | $341.91M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $352.79M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $363.30M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $374.20M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $385.91M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $397.00M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $408.35M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $419.69M 10-Q · filed 2012-05-08 | |
| 2011-12-31 | $431.04M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $95.76M 10-Q · filed 2011-11-09 | |
| 2011-06-30 | $98.65M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $64.58M 10-K · filed 2012-02-28 |